Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Field experimentation enhances translation for behavioral neuroscience
    Published on 2025-07-25
    1 year ago
  • Understanding the emergence of suicidal thoughts and behaviors in adolescence from a brain and behavioral developmental perspective
    Published on 2025-07-25
    1 year ago
  • Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
    Published on 2025-07-24
    1 year ago
  • Timing matters: modeling the effects of gestational cannabis exposure on social behavior and microglia in the developing amygdala
    Published on 2025-07-23
    1 year ago
  • Estrous cycle stage gates the effect of stress on reward learning
    Published on 2025-07-16
    1 year ago
  • Social Determinants of Health, the developing brain, and risk and resilience for psychopathology
    Published on 2025-07-16
    1 year ago
  • Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study
    Published on 2025-07-15
    1 year ago
« Previous 1 … 54 55 56 57 58 … 143 Next »
Journal of Psychopharmacology
  • Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
    Published on 2024-04-05
    2 years ago
  • Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review
    Published on 2024-03-27
    2 years ago
  • Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder
    Published on 2024-03-23
    2 years ago
  • Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression
    Published on 2024-03-23
    2 years ago
  • The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients
    Published on 2024-03-23
    2 years ago
  • Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial
    Published on 2024-03-23
    2 years ago
  • Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I
    Published on 2024-03-18
    2 years ago
« Previous 1 … 54 55 56 57 58 … 154 Next »
European Neuropsychopharmacology
  • Social cognition in maltreated individuals: Do type and timing of maltreatment matter?
    Published on 2024-02-07
    3 years ago
  • Using digital phenotyping to classify bipolar disorder and unipolar disorder – exploratory findings using machine learning models
    Published on 2024-02-04
    3 years ago
  • Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data
    Published on 2024-02-04
    3 years ago
  • Can cognition screening in the clinic aid personalised treatment in bipolar disorder?
    Published on 2024-02-04
    3 years ago
  • Should lithium be used in children and adolescents with bipolar disorder?
    Published on 2024-02-04
    3 years ago
  • Society Calendar
    Published on 2024-02-03
    3 years ago
  • Editorial Board
    Published on 2024-02-03
    3 years ago
« Previous 1 … 54 55 56 57 58 … 170 Next »

   Pharma Pub